Clinical Trial Update: Haplo-HSCT for Myelofibrosis [NA]

View source ↗

Summary

A clinical trial investigating haploidentical hematopoietic stem cell transplantation for myelofibrosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis

Snippet

Sponsor: Peking University People's Hospital | Conditions: Myelofibrosis | NA | Status: RECRUITING